X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
STRIDES PHARMA SCIENCE Fact Sheet, STRIDES PHARMA SCIENCE Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Fact Sheet   (PLLB)

Here is the latest financial fact sheet of STRIDES PHARMA SCIENCE. For more details, see the STRIDES PHARMA SCIENCE quarterly results and STRIDES PHARMA SCIENCE share price and chart. For a sector overview, read our pharmaceuticals sector report.

STRIDES PHARMA SCIENCE Price History

Price Rs 470.5
Mkt Cap Rs m 28,065
Vol '000 51.0
P/E X 52.5
P/CF X 11.6
EPS (TTM) Rs 9.0
% ch % 0.6
No. of shares m 59.65
% ch week % 9.2
% ch 1-mth % 2.0
% ch 12-mth % -41.0
52 week H/L Rs 855.2/334.1
(As on Dec 18, 2018 03:35:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

STRIDES PHARMA SCIENCE Financials

No. of Mths
Year Ending
15
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
STRIDES PHARMA SCIENCE EQUITY SHARE DATA
High Rs1,1381,1991,4131,2751,147 
Low Rs344384848918642 
Sales per share (Unadj.) Rs225.1200.6320.3308.1317.2 
Earnings per share (Unadj.) Rs296.6141.713.231.37.8 
Diluted earnings per shareRs296.2141.719.846.911.8 
Cash flow per share (Unadj.) Rs306.1152.527.945.425.1 
Dividends per share (Unadj.) Rs505.00108.005.004.502.00 
Adj. dividends per shareRs504.32107.957.496.753.00 
Dividend yield (eoy) %68.213.70.40.40.2 
Book value per share (Unadj.) Rs169.0193.9297.5307.4274.3 
Adj. book value per shareRs168.8193.8445.6460.8411.5 
Shares outstanding (eoy) m59.5759.6289.3589.4289.50 
Bonus/Rights/Conversions  ESOPESOPESOPESOPESOP 
Price / Sales ratio x3.33.93.53.62.8 
Avg P/E ratio x2.55.685.535.1114.0 
P/CF ratio (eoy) x2.45.240.524.235.7 
Price / Book Value ratio x4.44.13.83.63.3 
Dividend payout %170.376.237.814.425.5 
Avg Mkt Cap Rs m44,13547,165100,98898,03680,058 
No. of employees `0001.52.04.75.82.5 
Total wages/salary Rs m1,5721,7213,5774,1924,341 
Avg. sales/employee Rs Th8,939.55,979.36,102.84,750.811,325.8 
Avg. wages/employee Rs Th1,047.9860.3762.7722.71,731.4 
Avg. net profit/employee Rs Th11,778.34,225.0251.9482.2280.1 
STRIDES PHARMA SCIENCE INCOME DATA
Net Sales Rs m13,40911,95928,62227,55428,394 
Other income Rs m6023869211,611941 
Total revenues Rs m14,01212,34429,54329,16529,334 
Gross profit Rs m2,2342,2894,1405,2743,965 
Depreciation Rs m5656401,3131,2621,540 
Interest Rs m1,0894741,6821,8311,962 
Profit before tax Rs m1,1831,5602,0673,7921,403 
Minority Interest Rs m-66000 
Prior Period Items Rs m00-474-168 
Extraordinary Inc (Exp) Rs m19,7368,361-414-364-436 
Tax Rs m3,2451,47642563497 
Profit after tax Rs m17,6678,4501,1812,797702 
Gross profit margin %16.719.114.519.114.0 
Effective tax rate %274.394.620.516.76.9 
Net profit margin %131.870.74.110.22.5 
STRIDES PHARMA SCIENCE BALANCE SHEET DATA
Current assets Rs m13,08614,44735,14937,91824,836 
Current liabilities Rs m7,07410,02218,92031,03918,993 
Net working cap to sales %44.837.056.725.020.6 
Current ratio x1.81.41.91.21.3 
Inventory Days Days4863789771 
Debtors Days Days99112132132113 
Net fixed assets Rs m5,5068,40035,68237,63934,289 
Share capital Rs m596596894894895 
"Free" reserves Rs m4,59410,96225,68526,59423,651 
Net worth Rs m10,06811,55826,57927,48824,546 
Long term debt Rs m2,7552,53026,27016,37715,513 
Total assets Rs m20,99024,80574,55981,05065,437 
Interest coverage x2.14.32.23.11.7 
Debt to equity ratio x0.30.21.00.60.6 
Sales to assets ratio x0.60.50.40.30.4 
Return on assets %89.436.03.85.74.1 
Return on equity %175.573.14.410.22.9 
Return on capital %171.673.86.212.06.9 
Exports to sales %59.460.253.100 
Imports to sales %20.523.515.900 
Exports (fob) Rs m7,9597,20415,19200 
Imports (cif) Rs m2,7522,8094,56500 
Fx inflow Rs m22,79113,03116,61213,46515,697 
Fx outflow Rs m3,0883,1655,2924,076735 
Net fx Rs m19,7039,86511,3209,38914,962 
STRIDES PHARMA SCIENCE CASH FLOW
From Operations Rs m -2,717 834 733 2,881 1,871 
From Investments Rs m 40,771 519 -22,248 -6,867 5,826 
From Financial Activity Rs m -33,185 -4,213 29,439 3,382 -10,157 
Net Cashflow Rs m 4,869 -2,860 7,924 -603 -2,615 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 27.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 37.8%
FIIs 8.6%
ADR/GDR 0.0%
Free float 25.9%
Shareholders 56,241
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 201, Devavrata, Sector 17, Vashi, Navi Mumbai - 400 705
E-MAIL badree.komandur@stridesarco.com WEB www.stridesarco.com
TELEPHONE (080) 6784 0000 FAX (080) 6784 0800
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Deepak Vaidya (MD) COMP SEC: Badree Komandur (EVP-Finance) YEAR OF INC: 1980 BSE CODE: 532531 FV (Rs): 10 DIV YIELD (%): 0.6

Read: STRIDES SHASUN LTD 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES  BIOCON LTD  WOCKHARDT LTD.  FULFORD INDIA  AUROBINDO PHARMA  

Compare STRIDES PHARMA SCIENCE With:   DIVIS LABORATORIES  BIOCON LTD  WOCKHARDT LTD.  FULFORD INDIA  AUROBINDO PHARMA  

Compare STRIDES PHARMA SCIENCE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Recover; Sensex Ends 77 Points Higher(Closing)

Indian share markets witnessed buying interest during closing hours and ended on a positive note. Gains were seen in the metal sector.

Views on news

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY19); Net Profit Down 72.2% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 54 m (down 72.2% YoY). Sales on the other hand came in at Rs 7 bn (down 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES SHASUN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Oct 1, 2018 | Updated on Oct 1, 2018

Here's an analysis of the annual report of STRIDES SHASUN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES SHASUN LTD. Also includes updates on the valuation of STRIDES SHASUN LTD.

STRIDES SHASUN LTD Announces Quarterly Results (1QFY19); Net Profit Down 57.5% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, STRIDES SHASUN LTD has posted a net profit of Rs 38 m (down 57.5% YoY). Sales on the other hand came in at Rs 7 bn (down 21.2% YoY). Read on for a complete analysis of STRIDES SHASUN LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Patel's Exit, Election Results, and 4 'Must Have' Small Caps in These Exceptional Times(Profit Hunter)

Dec 11, 2018

RBI Governor's resignation is a statement of dissent with the way government is handling the economy's affairs and could lead to some serious market correction. Here's how to make the most of it.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE - TEVA PHARMA COMPARISON

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS